4th Annual Asia Pacific Life Sciences Forum

London, 10-11 October 2007

Following three consecutive years of success, the 4th Annual Asia Pacific Life Sciences Forum will showcase a select group of Asia Pacific biotechnology companies to UK & EU investor and partnering audiences interested in the Asia Pacific region.

Attendance is free for media, qualifying analysts, fund managers, investors, venture capitalists, biotech and pharma executives.

Day One is a closed briefing session for Presenting Companies with scheduled partnering meetings taking place in the afternoon, while Day Two is open for all delegates to attend and hear the Company presentations. Formal and informal networking functions will include an evening hosted by the Governor of Victoria Professor David de Kretser.

Organising sponsors include Intersuisse BioScience Managers, Elixir Securities, Grant Thornton and Northbank Communications.

For more information, please visit http://www.aplsf.com or contact Intersuisse Elizabeth Steyn on +61 (0)3 9629 8380 or esteyn@intersuisse.com.au

Interesting facts about the Australian biotechnology industry:

The number of core biotechnology companies in Australia has more than doubled over a period of five years to 427 in 2006.

  • As at December 2006, the market capitalisation for biotechnology and medical devices companies listed on the Australia Stock Exchange (ASX) was A$26.5 billion.

  • Approximately 50 per cent of the biotechnology companies listed on the Australia Stock Exchange (ASX) have emerged from publicly funded research agencies.

  • In 2006, Australian biotechnology companies and research organisations announced 380 partnerships, 67 per cent with overseas companies or agencies.

  • The Australian biotechnology industry has 474 therapeutic products in development.

  • With only 0.3 per cent of the world’s population, Australia contributes 2.5 per cent of the world’s media research and 2.9 per cent of global scientific publications.

  • Australia is the home of ground breaking Nobel Laureates - Howard Florey (Penicillin), John Eccles (Neurophysiology), William Bragg (X-Ray Crystallography), John Cornforth (Enzyme Chemistry), Frank Macfarlane Burnet (Immunology), Peter Doherty (Immunology).

Source: Australian Government Invest Australia Biotechnology Industry Report, 2007